US Stock MarketDetailed Quotes

ABIO ARCA biopharma

Watchlist
  • 3.700
  • +0.230+6.63%
Close May 31 16:00 ET
  • 4.000
  • +0.300+8.11%
Post 19:49 ET
53.68MMarket Cap-8809P/E (TTM)

ARCA biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.20%-1.53M
54.05%-5.01M
29.32%-1.06M
33.19%-1.67M
73.53%-694K
62.89%-1.6M
41.84%-10.91M
69.80%-1.49M
48.71%-2.5M
29.52%-2.62M
Net income from continuing operations
-49.26%-2.01M
46.21%-5.34M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
48.63%-9.93M
79.32%-1.17M
50.49%-2.33M
34.90%-3.15M
Operating gains losses
----
----
----
----
----
----
--5K
--0
--3K
--0
Depreciation and amortization
-34.48%19K
-2.63%111K
-20.69%23K
7.14%30K
0.00%29K
3.57%29K
25.27%114K
3.57%29K
3.70%28K
52.63%29K
Change In working capital
172.20%348K
71.58%-472K
72.07%-131K
-46.42%-429K
75.93%570K
60.59%-482K
-5,832.14%-1.66M
-180.58%-469K
-1.38%-293K
-66.32%324K
-Change in payables and accrued expense
722.41%954K
76.87%-571K
54.60%-375K
30.11%-629K
380.30%317K
114.34%116K
-720.27%-2.47M
-507.35%-826K
-64.53%-900K
-92.00%66K
-Change in other current assets
-1.34%-606K
-87.75%99K
-31.65%244K
-67.05%200K
-1.94%253K
-44.44%-598K
598.77%808K
26.15%357K
135.27%607K
88.32%258K
Cash from discontinued investing activities
Operating cash flow
4.20%-1.53M
54.05%-5.01M
29.32%-1.06M
33.19%-1.67M
73.53%-694K
62.89%-1.6M
41.84%-10.91M
69.80%-1.49M
48.71%-2.5M
29.52%-2.62M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
95.35%-2K
0
0
0
Net PPE purchase and sale
----
--0
--0
--0
----
----
95.35%-2K
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
95.35%-2K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-11.81%37.43M
-20.45%42.45M
-12.41%38.49M
-13.53%40.16M
-16.73%40.85M
-20.45%42.45M
8.74%53.36M
-24.65%43.94M
-26.52%46.44M
-26.70%49.06M
Current changes in cash
4.20%-1.53M
54.06%-5.01M
29.32%-1.06M
33.19%-1.67M
73.53%-694K
62.91%-1.6M
-354.52%-10.91M
69.84%-1.49M
48.85%-2.5M
29.82%-2.62M
End cash Position
-12.11%35.9M
-11.81%37.43M
-11.81%37.43M
-12.41%38.49M
-13.53%40.16M
-16.73%40.85M
-20.45%42.45M
-20.45%42.45M
-24.65%43.94M
-26.52%46.44M
Free cash flow
4.20%-1.53M
54.06%-5.01M
29.32%-1.06M
33.19%-1.67M
73.53%-694K
62.91%-1.6M
41.96%-10.91M
69.84%-1.49M
48.85%-2.5M
29.82%-2.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.20%-1.53M54.05%-5.01M29.32%-1.06M33.19%-1.67M73.53%-694K62.89%-1.6M41.84%-10.91M69.80%-1.49M48.71%-2.5M29.52%-2.62M
Net income from continuing operations -49.26%-2.01M46.21%-5.34M7.24%-1.09M38.96%-1.42M52.97%-1.48M58.86%-1.35M48.63%-9.93M79.32%-1.17M50.49%-2.33M34.90%-3.15M
Operating gains losses --------------------------5K--0--3K--0
Depreciation and amortization -34.48%19K-2.63%111K-20.69%23K7.14%30K0.00%29K3.57%29K25.27%114K3.57%29K3.70%28K52.63%29K
Change In working capital 172.20%348K71.58%-472K72.07%-131K-46.42%-429K75.93%570K60.59%-482K-5,832.14%-1.66M-180.58%-469K-1.38%-293K-66.32%324K
-Change in payables and accrued expense 722.41%954K76.87%-571K54.60%-375K30.11%-629K380.30%317K114.34%116K-720.27%-2.47M-507.35%-826K-64.53%-900K-92.00%66K
-Change in other current assets -1.34%-606K-87.75%99K-31.65%244K-67.05%200K-1.94%253K-44.44%-598K598.77%808K26.15%357K135.27%607K88.32%258K
Cash from discontinued investing activities
Operating cash flow 4.20%-1.53M54.05%-5.01M29.32%-1.06M33.19%-1.67M73.53%-694K62.89%-1.6M41.84%-10.91M69.80%-1.49M48.71%-2.5M29.52%-2.62M
Investing cash flow
Cash flow from continuing investing activities 00095.35%-2K000
Net PPE purchase and sale ------0--0--0--------95.35%-2K--0--0--0
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--095.35%-2K--0--0--0
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Financing cash flow --0--0--0--0--0--0--0--0--0--0
Net cash flow
Beginning cash position -11.81%37.43M-20.45%42.45M-12.41%38.49M-13.53%40.16M-16.73%40.85M-20.45%42.45M8.74%53.36M-24.65%43.94M-26.52%46.44M-26.70%49.06M
Current changes in cash 4.20%-1.53M54.06%-5.01M29.32%-1.06M33.19%-1.67M73.53%-694K62.91%-1.6M-354.52%-10.91M69.84%-1.49M48.85%-2.5M29.82%-2.62M
End cash Position -12.11%35.9M-11.81%37.43M-11.81%37.43M-12.41%38.49M-13.53%40.16M-16.73%40.85M-20.45%42.45M-20.45%42.45M-24.65%43.94M-26.52%46.44M
Free cash flow 4.20%-1.53M54.06%-5.01M29.32%-1.06M33.19%-1.67M73.53%-694K62.91%-1.6M41.96%-10.91M69.84%-1.49M48.85%-2.5M29.82%-2.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg